Visual results of intraocular lenses (IOLs)
| Author | IOL | Design | Study design | Number of eyes | UCNVA | BDCNVA | Additional tests | Complications |
|---|---|---|---|---|---|---|---|---|
| Forte and Ursoleo48 | ReZoom | Refractive | 2 years | 55 | 0.10 logMAR (monocular) | Not available | ▸ UCIVA 0.07 logMAR (monocular). ▸ 7% patients reported moderate glare ▸ 5% patients reported moderate halo | Not reported |
| Cezon et al50 | Rayner M-flex | Refractive | 1 year | 32 | 0.28 logMAR (monocular) | 0.28 logMAR (monocular) | ▸ UCIVA 0.15 logMAR ▸ CIVA 0.15 logMAR (monocular). | Not reported |
| Kohnen et al54 | AcrySof ReSTOR MA60D3 | Diffractive | 6 months | 127 | 0.14 logMAR in 66.9% (binocular) | 0.14 logMAR in 71.2% (binocular) | ▸ 84.6% spectacle independence for near vision ▸ 8.5% patients reported severe glare ▸ 4.2% patients reported severe halo | ▸ 2 eyes implant replacements ▸ 2 eyes with cystoid macular oedema ▸ 1 eye flat macular oedema ▸ 1 eye macular oedema with fibrous reaction ▸ 1 cystic maculopathy |
| Packer et al55 | Tecnis multifocal | Diffractive | 1 year | 244 | 0.20 logMAR (monocular) 0.10 logMAR (binocular) | 0.18 logMAR (monocular) 0.10 logMAR (binocular) | ▸ 95.5% spectacle independency for distance vision ▸ 86.6% spectacle independency for near vision ▸ 94.6% satisfied ▸ 10.3% patients reported moderate glare ▸ 2.6% patients reported severe glare ▸ 84.8% spectacle independence | ▸ 1 pupilloplasty ▸ 4 IOL explantation ▸ 12.8% eyes required Yag laser |
| Mojzis et al57 | AT Lisa tri 839MP | Diffractive trifocal | 6 months | 60 | 0.20 logMAR (monocular) | 0.17 logMAR (monocular) | ▸ UCIVA 0.08 logMAR ▸ DCIVA 0.08 logMAR (monocular) | Not surgical complications |
| Sheppard et al58 | Finevision trifocal | Diffractive trifocal | 2 months | 30 | Not available | Not available | ▸ UCDVA 0.19 logMAR (monocular) ▸ NAVQ Rasch scores satisfaction at near 15.9 logits | Not reported |
| Voskresenskaya et al56 | MIOL-Record trifocal | Diffractive trifocal | 6 months | 36 | 0.10 logMAR (monocular) | 0.10 logMAR (monocular) | ▸ UCIVA, DCIVA 0.2 logMAR, Scotopic ▸ CS 0.2 log unit below standard values at all spatial frequencies ▸ 94% patients reported spectacle freedom ▸ 25% patients reported haloes | Not surgical complications |
| Shah (2014) | Lentis Mplus X LS-313 | Rotationally asymmetrical | 3 months | 34 | 0.18 logMAR (monocular) | 0.15 logMAR (monocular) | NAVQ Rasch scores satisfaction at near 20.43 logits | Not surgical complications |
| Venter et al63 | SBL-3 | Rotationally asymmetrical | 3 months | 106 | 0.12 logMAR (monocular); ▸ 0.08 logMAR (binocular) | 0.11 logMAR (monocular); ▸ 0.08 logMAR (binocular); | ▸ UCIVA 0.16 logMAR (monocular) and 0.13 logMAR (binocular) ▸ DCIVA 0.15 logMAR (monocular) and 0.1 logMAR)(binocular) ▸ 94.4% satisfied or very satisfied ▸ 86.8% had no difficulty at all or little difficulty performing tasks that require good close-up vision | Not surgical complications |
| Baikoff et al64 | Anterior pIOL | Refractive | 1 year | 55 | 0.23 logMAR (monocular) | Not available | ▸ Efficacy ratio of 80% ▸ Safety ratio of 94% | ▸ Slight pupil ovalisation in 10% eyes ▸ Mean endothelium cell loss less than 5% ▸ 4 IOL explantations because of dissatisfaction |
| Alio and Mulet 65 | The AMO multifocalphakic IOL prototype | Refractive | 1 year | 34 | 0.20 logMAR (binocular) | Not available | ▸ UCIVA 0.00 (binocular) ▸ Stereopsis near 80.62 s of arc ▸ Patient satisfaction very good in 88% patients | Not surgical complications |
| Cumming et al66 | Crystalens AT-45 | Accommodative | 1 year FDA clinical trial | 263 eyes | 0.20 logMAR or better in 93.5% (binocular) | 0.20 logMAR or better in 83.9% (binocular) | ▸ DCIVA 0.1 in 95% eyes (binocular) ▸ 25.8% patients reported spectacle freedom | ▸ Endophthalmitis 1 eye ▸ 12 eyes IOL dislocation ▸ 2 eyes retinal detachment ▸ 1 eye iridectomy ▸ 1 eye with persistent corneal oedema ▸ 3 eyes with iritis |
| Sanders and Sanders67 | Tetraflex | Accommodative | 1 year FDA clinical study | 255 | 0.4 logMAR in 77% | 0.4 logMAR or better in 67% | ▸ 90% could read ≥ 80 wpm at the 0.2 logMAR print size ▸ 75% patients reported never or occasionally wore near glasses | Malpositioning of 5 IOLS |
| Mastropasqua et al68 | 1CU Human Optics | Accommodative | 2 years | 14 | Not available | 0.2 logMAR at 6 months 0.48 logMAR at 2 years | AA 1.9 D at 6 months and 0.30 D at 2 years | Anterior and posterior opacification in 100% of cases |
| Alió (2009)75 | The NuLens | Accommodative | 1 year | 10 (Cataract and atrophic macular degeneration) | Increase of 3.8 Jaeger rows (6 months) | Not available | Cross-section measurement of IOL of 0.09 mm (equivalent to 10 D) | ▸ 1 posterior synechia inducing IOL tilt ▸ 1 capsulorhexis edge capture by the haptic endplate inducing high myopia |
Note: some visual acuities were converted to logMAR using the visual acuity conversion chart prepared by Jack T Holland.
AA, amplitude of accommodation; BDCNVA, best distance corrected near visual acuity; CIVA, corrected intermediate visual acuity; CS, contrast sensitivity; DCIVA, distance corrected intermediate visual acuity; LogMAR, log minimum angle of resolution; MIOL, multifocal intraocular lens; UCIVA, uncorrected intermediate visual acuity; NAVQ, Near Assessment of Vision Questionnaire; pIOL, phakic intraocular lens; UCNVA, uncorrected near visual acuity.